|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q1 FY2016
As of Apr 30, 2016
|
Q4 FY2015
As of Jan 31, 2016
|
Q3 FY2015
As of Oct 31, 2015
|
Q2 FY2015
As of Jul 31, 2015
|
Q1 FY2015
As of Apr 30, 2015
|
Q4 FY2014
As of Jan 31, 2015
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | |||||||||
| Prepaid expenses | |||||||||
| Restricted cash | |||||||||
| Accounts receivable | |||||||||
| Processing assets | |||||||||
| Other receivables | |||||||||
| Related-party receivables | |||||||||
| Prepaid income taxes | |||||||||
| Other prepaid expenses | |||||||||
| Other current assets | |||||||||
| Total current assets | |||||||||
| Cash and securities held in Trust Account | |||||||||
| Deferred offering costs | |||||||||
| Property and equipment, net | |||||||||
| Other assets: | |||||||||
| Long-term restricted cash | |||||||||
| Long-term related-party receivables | |||||||||
| Long-term other receivables | |||||||||
| Goodwill | |||||||||
| Intangible assets, net | |||||||||
| Long-term other assets | |||||||||
| Total assets | |||||||||
| Liabilities and stockholders’ deficit | |||||||||
| Accounts payable and accrued expenses | |||||||||
| Loan from sponsor | |||||||||
| Accrued offering costs | |||||||||
| Promissory note - related party | |||||||||
| Current liabilities: | |||||||||
| Accounts payable | |||||||||
| Residuals payable | |||||||||
| Processing liabilities | |||||||||
| Settlement obligation | |||||||||
| Accrued expenses | |||||||||
| Income tax payable | |||||||||
| Current portion of long-term debt | |||||||||
| Deferred revenue | |||||||||
| Total current liabilities | |||||||||
| Deferred underwriting fees | |||||||||
| Deferred underwriting fees | |||||||||
| Deferred legal fees payable | |||||||||
| Long-term liabilities: | |||||||||
| Accrued expenses | |||||||||
| Long-term debt | |||||||||
| Deferred tax liability | |||||||||
| Total long-term liabilities | |||||||||
| Total liabilities | |||||||||
| Commitments and contingencies (Note 5) | |||||||||
| Redeemable Series A Preferred Stock, par value $0.001, 1,500,000 shares issued and outstanding; liquidation value of $37,864,620 and $37,729,737 at March 31, 2017 and December 31, 2016, respectively, net of offering costs | |||||||||
| Stockholders’ deficit: | |||||||||
| Preferred stock, par value $0.001, 10,000,000 shares authorized; no shares issued and outstanding (which excludes 1,500,000 shares of Series A Preferred Stock issued and outstanding at March 31, 2017 and December 31, 2016) | |||||||||
| Common stock, par value $0.001; 200,000,000 shares authorized; 29,165,365 and 29,051,348 shares issued and outstanding at March 31, 2017 and December 31, 2016, respectively | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Treasury stock of 681,538 common shares at December 31, 2015, at cost | |||||||||
| Total stockholders’ deficit | |||||||||
| Total liabilities and stockholders’ deficit |
Loading...
